Does a high omega-6/omega-3 ratio impair insulin signaling via pro-inflammatory lipid mediators?

The relationship between dietary fatty acid ratios and metabolic health is a critical factor in systemic inflammation and the long-term maintenance of glucose homeostasis. In older adults, the balance of these lipids plays a significant role in preserving insulin sensitivity.

Mechanistic basis of lipid mediator imbalance

A high omega-6 to omega-3 ratio shifts the cellular environment toward a pro-inflammatory state through competitive enzymatic pathways. Omega-6 fatty acids, specifically arachidonic acid (AA), serve as primary substrates for cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP) enzymes. These pathways generate potent pro-inflammatory eicosanoids such as prostaglandin E2 (PGE2) and leukotriene B4 (LTB4). Conversely, omega-3 fatty acids (EPA and DHA) act as competitive inhibitors for these same enzymes, shunting metabolism toward less inflammatory 3-series prostaglandins and specialized pro-resolving mediators (SPMs) like resolvins and protectins. Without sufficient omega-3 levels, the lack of competitive pressure allows for unregulated synthesis of inflammatory mediators and impairs the physiological resolution of inflammatory signals.

Disruption of insulin signaling pathways

Chronic exposure to these pro-inflammatory mediators and associated lipid metabolites (such as diacylglycerols and ceramides) directly impairs the insulin signaling cascade. These molecules activate key stress kinases, notably c-Jun N-terminal kinase (JNK) and IκB kinase-β (IKK-β). These kinases catalyze the inhibitory serine phosphorylation of Insulin Receptor Substrate-1 (IRS-1), specifically at sites like Ser307. This modification prevents the essential tyrosine phosphorylation of IRS-1 by the insulin receptor, effectively blocking the downstream PI3K-Akt signaling pathway. Consequently, the translocation of glucose transporter 4 (GLUT4) to the cell membrane is reduced, resulting in decreased cellular glucose uptake and systemic insulin resistance over time.

Bottom line

• A high omega-6/omega-3 ratio promotes a pro-inflammatory milieu that actively disrupts the IRS-1/PI3K/Akt signaling axis, leading to impaired insulin sensitivity and increased risk of metabolic dysfunction.